Specifically, the TGF-β1-509 C/T polymorphism is associated with increased TGF-β1 levels and increased risk of liver fibrosis and cirrhosis in HCV-infected patients [14-15]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.